| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:41 UTC |
|---|
| Update date | 2024-11-29 22:26:10 UTC |
|---|
| Primary ID | FDB000710 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Choline |
|---|
| Description | Choline, also known as bilineurine, is an organic compound containing a N, N, N-trimethylethanolammonium cation. Choline is an extremely weak basic (essentially neutral) compound (based on its pKa). Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. In plants, the first step in de novo biosynthesis of choline involves the decarboxylation of serine into ethanolamine, which is catalyzed by a serine decarboxylase. The synthesis of choline from ethanolamine involves three consecutive N-methylation steps catalyzed by a methyl transferase. In terms of human health, choline is now considered to be an essential vitamin. While humans can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver, and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine into methionine). Lack of sufficient amounts of choline in the diet can lead to fatty liver disease and general liver damage. This arises from the lack of VLDL , which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer. |
|---|
| CAS Number | 62-49-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| Bilineurine | ChEBI | | CHOLINE ion | ChEBI | | N,N,N-Trimethylethanol-ammonium | ChEBI | | N-Trimethylethanolamine | ChEBI | | Trimethylethanolamine | ChEBI | | Choline cation | Kegg | | (2-Hydroxyethyl)trimethyl ammonium | HMDB | | (2-Hydroxyethyl)trimethylammonium | HMDB | | (beta-Hydroxyethyl)trimethylammonium | HMDB | | 2-Hydroxy-N,N,N-trimethyl-ethanaminium | HMDB | | 2-Hydroxy-N,N,N-trimethylethanaminium | HMDB | | Biocolina | HMDB | | Biocoline | HMDB | | Cholinum | HMDB | | Hepacholine | HMDB | | Hormocline | HMDB | | Lipotril | HMDB | | N,N,N-Trimethylethanolammonium | HMDB | | Neocolina | HMDB | | Paresan | HMDB | | Choline O-sulfate | HMDB | | Citrate, choline | HMDB | | Fagine | HMDB | | Hydroxide, choline | HMDB | | Vidine | HMDB | | Bursine | HMDB | | Chloride, choline | HMDB | | Choline chloride | HMDB | | Choline citrate | HMDB | | Bitartrate, choline | HMDB | | Choline bitartrate | HMDB | | Choline hydroxide | HMDB | | Choline O sulfate | HMDB | | O-Sulfate, choline | HMDB | | 2-Hydroxy-N,N,N-trimethylethanaminium(1+), 9CI | db_source | | 2-Hydroxyethyl-trimethylazanium | biospider | | Amanitin? | db_source | | Arachine | db_source | | Araquine | db_source | | Choline (8CI) | biospider | | Choline ion | biospider | | Ethanaminium, 2-hydroxy-N,N,N-trimethyl- (9CI) | biospider | | Sincalin | db_source | | Sinkalin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C5H14NO |
|---|
| IUPAC name | (2-hydroxyethyl)trimethylazanium |
|---|
| InChI Identifier | InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1 |
|---|
| InChI Key | OEYIOHPDSNJKLS-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | C[N+](C)(C)CCO |
|---|
| Average Molecular Weight | 104.1708 |
|---|
| Monoisotopic Molecular Weight | 104.107539075 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as cholines. These are organic compounds containing a N,N,N-trimethylethanolammonium cation. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Quaternary ammonium salts |
|---|
| Direct Parent | Cholines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Choline
- Tetraalkylammonium salt
- 1,2-aminoalcohol
- Alkanolamine
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic salt
- Primary alcohol
- Organooxygen compound
- Amine
- Alcohol
- Organic cation
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Biological role: Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 57.65%; H 13.55%; N 13.45%; O 15.36% | DFC |
|---|
| Melting Point | 302-303 oC (Chloride salt) | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | +1 | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Choline, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-05fr-9100000000-69389426dd865af031f9 | Spectrum | | Predicted GC-MS | Choline, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-05g0-9300000000-ca1b0086d4882b00b395 | Spectrum | | Predicted GC-MS | Choline, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Choline, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-0a4i-0900000000-ea6f9c1150759c5be6c7 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-0a4i-1900000000-cadf16d18f093e9b19d6 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-0bt9-9100000000-a2c328b7da5435b8e467 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive | splash10-0udi-0900000000-6a7b57dbdf4560721722 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive | splash10-0udi-5900000000-87fdeef5275a74e78348 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-0w29-5900000000-9b79cc5ff3b1ce17deb1 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-03di-9200000000-fe62d5a4fbf492493d60 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-IT , positive | splash10-0udi-3900000000-0b37e63e9c6b14a2e397 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-0udi-0900000000-6a7b57dbdf4560721722 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-0udi-5900000000-87fdeef5275a74e78348 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-0pb9-1900000000-391c1b7859a03e776123 | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-2900000000-43b0f930ff04f7a48a59 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0udr-9400000000-ab7cc75a8e0d3cc49449 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-000i-9000000000-0b94edfd44e38b20b8d3 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-9100000000-a738404b52e2f1f6fec1 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-9000000000-c596e40769889223b3dd | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03di-9000000000-c6fab16d1790976560b5 | 2021-09-24 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 299 |
|---|
| ChEMBL ID | CHEMBL920 |
|---|
| KEGG Compound ID | C00114 |
|---|
| Pubchem Compound ID | 305 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 15354 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00122 |
|---|
| HMDB ID | HMDB00097 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BFT67-H:BFT67-H |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | CHOLINE |
|---|
| BIGG ID | 33910 |
|---|
| KNApSAcK ID | C00007298 |
|---|
| HET ID | CHT |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Choline |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-Alzheimeran | 52217 | An agent that inhibits the progression of Alzheimer's disease, reducing beta-amyloid plaque formation and neuroinflammation. Therapeutically, it improves cognitive function and memory, commonly used in managing mild to moderate Alzheimer's disease and other neurodegenerative disorders. | DUKE | | Anti-choreic | 52217 | An agent that reduces involuntary movements, commonly used in managing neurological disorders such as Huntington's disease, Parkinson's disease, and tic disorders, by blocking excessive dopamine activity in the brain, thereby alleviating symptoms of chorea, athetosis, and dystonia. | DUKE | | Anti-cirrhotic | 52217 | An agent that prevents or treats liver cirrhosis, reducing fibrosis and promoting liver health. It inhibits liver scarring, commonly used in managing liver diseases such as hepatitis and fatty liver disease. | DUKE | | Anti-cystinuric | | An agent that reduces cystine stone formation in the kidneys, ureter, or bladder, used to manage cystinuria, a genetic disorder causing excessive cystine excretion. | DUKE | | Anti-dementia | 52217 | An agent that slows or prevents cognitive decline, reducing symptoms of dementia. It plays a biological role in neuroprotection, enhancing neuronal function and survival. Therapeutically, it is used to manage Alzheimer's disease, vascular dementia, and other neurodegenerative disorders, improving memory, cognition, and daily functioning. | DUKE | | Anti-diabetic | 52217 | An agent that regulates blood sugar levels, enhancing insulin sensitivity or secretion. Therapeutically, it's used to manage diabetes, reducing symptoms and complications, and commonly prescribed to treat type 1 and 2 diabetes, as well as gestational diabetes. | DUKE | | Anti dyskinetic | | An agent that relieves or prevents dyskinesia, improving voluntary movement. It plays a biological role in regulating motor function, and has therapeutic applications in managing Parkinson's disease, Huntington's disease, and other movement disorders, reducing involuntary movements and improving motor control. | DUKE | | Anti homocysteine | 35222 | An agent that reduces homocysteine levels, an amino acid linked to cardiovascular disease and neurological disorders. It plays a biological role in methionine metabolism and has therapeutic applications in preventing cardiovascular events, stroke, and dementia. Key medical uses include managing hyperhomocysteinemia, reducing cardiovascular risk, and treating conditions associated with elevated homocysteine levels. | DUKE | | Anti-manic | | An agent that stabilizes mood by controlling symptoms of mania, used to manage bipolar disorder, reducing excessive excitement and impulsivity, and preventing manic episodes. | DUKE | | Anti nociceptive | 35470 | An agent that reduces the sensitivity to painful stimuli, blocking the transmission of pain signals. Its biological role is to modulate pain perception, with therapeutic applications in managing acute and chronic pain. Key medical uses include treating headaches, arthritis, and post-surgical pain, as well as providing relief for cancer and neuropathic pain. | DUKE | | Anti steatotic | | An agent that prevents lipid accumulation in cells, reducing steatosis. It plays a biological role in maintaining cellular lipid homeostasis. Therapeutically, it has applications in managing fatty liver disease, obesity, and metabolic disorders, with key medical uses including treatment of non-alcoholic fatty liver disease (NAFLD) and steatohepatitis. | DUKE | | Cardiodepressant | 38070 | An agent that slows heart rate and reduces cardiac contractility, used to manage conditions like hypertension, angina, and arrhythmias, reducing the heart's workload and oxygen demand. | DUKE | | Cerebrotonic | | A personality type characterized by shyness, introspection, and emotional restraint, often linked to an ectomorphic physique. It has no direct biological role or therapeutic applications, but understanding cerebrotonic traits can inform approaches to anxiety, social anxiety, or introversion management, and may be relevant in counseling or psychotherapy. | DUKE | | Cholinergic | 38323 | An agent that stimulates the parasympathetic nervous system by mimicking acetylcholine, enhancing muscle contraction, and regulating various bodily functions. Therapeutically, it treats conditions like glaucoma, myasthenia gravis, and Alzheimer's disease, improving muscle tone, cognition, and eye pressure. | DUKE | | Hepatoprotective | 62868 | An agent that protects the liver from damage, promoting liver health and function. It plays a biological role in reducing oxidative stress and inflammation, and has therapeutic applications in managing liver diseases, such as hepatitis and cirrhosis, and key medical uses in treating drug-induced liver injury and toxicities. | DUKE | | Hypotensive | | An agent that lowers blood pressure, playing a biological role in regulating cardiovascular function. Therapeutically, it's used to manage hypertension, heart failure, and angina, with key medical applications in preventing stroke, kidney disease, and cardiac complications. | DUKE | | Ileorelaxant | | An agent that reduces the muscular action of the ileum, playing a biological role in regulating intestinal motility. Therapeutically, it is used to relieve abdominal cramps, diarrhea, and irritable bowel syndrome (IBS) symptoms, making it a key medical treatment for gastrointestinal disorders. | DUKE | | Lipotropic | | A compound that facilitates fat breakdown and metabolism, playing a biological role in lipid utilization. Therapeutically, it's used to enhance weight loss and improve liver function. Key medical applications include treating fatty liver disease, obesity, and hyperlipidemia, making it a valuable agent in managing metabolic disorders. | DUKE | | Memorigenic | | An agent that enhances memory and cognitive function, playing a biological role in neuroprotection and neuroplasticity. Therapeutically, it has applications in managing neurodegenerative diseases, such as Alzheimer's and dementia, and key medical uses include improving memory recall and learning capacity. | DUKE | | Parasympathomimetic | | A substance that stimulates the parasympathetic nervous system, mimicking acetylcholine by activating nicotinic or muscarinic receptors. Therapeutically, it's used to treat conditions like glaucoma, asthma, and gastrointestinal disorders, promoting smooth muscle contraction and glandular secretion, while also slowing heart rate. | DUKE | | Neurotransmitter | 25512 | A chemical messenger that transmits signals between neurons, regulating various physiological and psychological processes. Therapeutically, neurotransmitter modulators are used to treat conditions such as depression, anxiety, and Parkinson's disease, by altering neurotransmitter levels or activity to restore balance and alleviate symptoms. | CHEBI |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Choline O-acetyltransferase | CHAT | P28329 | | Phospholipase D2 | PLD2 | O14939 | | Acetylcholinesterase | ACHE | P22303 | | Cholinesterase | BCHE | P06276 | | Choline-phosphate cytidylyltransferase B | PCYT1B | Q9Y5K3 | | Choline-phosphate cytidylyltransferase A | PCYT1A | P49585 | | Choline/ethanolamine kinase | CHKB | Q9Y259 | | Choline kinase alpha | CHKA | P35790 | | Phospholipase D3 | PLD3 | Q8IV08 | | Phospholipase D4 | PLD4 | Q96BZ4 | | Phospholipase D6 | PLD6 | Q8N2A8 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|